HIGHLIGHTS
- who: Nikolina Skandali et al. from the Department of Psychiatry, University of Cambridge, Cambridge, UK have published the research work: Psychological Medicine cambridge.org/psm, in the Journal: (JOURNAL)
- what: The authors show distinct neurochemical substrates underlying risk-taking with the dorsal cingulate cortex mu-opioid receptor binding associated with rewards and dorsal striatal serotonin transporter binding associated with losses. The authors examined the neurochemical correlates of risktaking as a function of valence across healthy controls and patient groups using three PET ligands to evaluate presynaptic DA function, and mu-opioid receptor and SERT binding . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.